(Q45083822)

9 December 2017

title

Seven years of treatment with risedronate in women with postmenopausal osteoporosis (English)

1 reference

9 December 2017

0 references

Mellström DD

1

1 reference

9 December 2017

Sörensen OH

2

1 reference

9 December 2017

Goemaere S

3

1 reference

9 December 2017

Roux C

4

1 reference

9 December 2017

Johnson TD

5

1 reference

9 December 2017

Chines AA

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

7 October 2004

1 reference

Calcified Tissue International

9 December 2017

published in

1 reference

9 December 2017

volume

75

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

462-468

1 reference

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Risk of new vertebral fracture in the year following a fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Ten years' experience with alendronate for osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

Preanalytical variability of biochemical markers of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-004-0286-7

10.1007/S00223-004-0286-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1007415759

0 references

1 reference